Genesis Mission #2: Why This Biotech Could Be The Next Big Runner
Автор: The Genesis Mission
Загружено: 2025-12-03
Просмотров: 13
Описание:
Title: Genesis Mission #2: Why This Biotech Could Be The Next Big Runner
Description: Is Spyre Therapeutics (SYRE) the next major biotech runner? The "Genesis Mission" continues, and today we are breaking down stock #2 of 92 in my master plan.
Spyre just hit a new 52-week high, fueled by a massive $316M financing deal and positive data for their "next-gen" IBD treatment. The stock has broken out of a key trendline and is now trading in "blue sky" territory with no overhead resistance.
In this video, I explain why their "long-acting" antibody technology is a game changer for patients, the specific technical setup I am trading, and how I am using the Uniqure (QURE) chart as a warning to strictly manage risk.
⚠️ DISCLAIMER: Not Financial Advice. The content in this video is for entertainment and educational purposes only. I am not a financial advisor. The ideas presented here are my own opinions and personal research. You must do your own due diligence (DYOR) before making any investment decisions. Investing in biotechnology stocks involves extreme risk and volatility.
#SYRE #SpyreTherapeutics #BiotechStocks #StockMarket #GenesisMission #SwingTrading #GrowthStocks #TechnicalAnalysis #Investing2025
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
